Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.41 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17723712 | 0.92 | PDK1 (0.42) | PDK1PDK2PDK3PDK4MEN1 | |
| SCHEMBL16097360 | 0.91 | PDK1 (0.42) | PDK1PDK2PDK3PDK4MEN1 | |
| SCHEMBL14721257 | 0.85 | CYP2C19 (0.42) | MEN1KMT2AMAPTCYP1A2CYP2C9 | |
| SCHEMBL14720800 | 0.83 | MEN1 (0.35) | PDK1PDK2PDK3PDK4MEN1 | |
| SCHEMBL14720769 | 0.76 | CYP1A2 (0.39) | LMNAMAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL14720572 | 0.74 | CYP2C19 (0.43) | MEN1KMT2AMAPTCYP1A2CYP2C9 | |
| SCHEMBL14721808 | 0.72 | CYP1A2 (0.31) | LMNACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL18677889 | 0.72 | — | — | |
| SCHEMBL1542395 | 0.70 | PDK1 (0.74) | PDK1PDK2PDK3PDK4MEN1 | |
| SCHEMBL16232839 | 0.70 | KMT2A (0.52) | MEN1KMT2ATSHRLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212733-B1 | NEW CHROMOPHORIC STRUCTURES FOR MACROCYCLIC LANTHANIDE CHELATES | RADIOMETER TURKU OY (FI) | 2019-08-28 | — | — | EP | disclosed |
| US-20170313936-A1 | NEW CHROMOPHORIC STRUCTURES FOR MACROCYCLIC LANTHANIDE CHELATES | RADIOMETER TURKU OY (FI) | 2017-11-02 | — | — | US | disclosed |
| US-20170313936-A1 | NEW CHROMOPHORIC STRUCTURES FOR MACROCYCLIC LANTHANIDE CHELATES | RADIOMETER TURKU OY (FI) | 2017-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170313936-A1 | NEW CHROMOPHORIC STRUCTURES FOR MACROCYCLIC LANTHANIDE CHELATES | UACA, CACYBP, LGALS3BP | PDK1 3231/4885PDK2 4308/4885PDK3 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.